1.
NRF2 activation induced by PML-RARĪ± promotes microRNA 125b-1 expression and confers resistance to chemotherapy in acute promyelocytic leukemia.
Yu, X, Mansouri, A, Liu, Z, Gao, R, Li, K, Chen, C, Huang, Y, Chen, Z, Chen, S, Lu, Y, et al
Clinical and translational medicine. 2021;(5):e418
2.
MicroRNA-138 suppresses epithelial-mesenchymal transition in squamous cell carcinoma cell lines.
Liu, X, Wang, C, Chen, Z, Jin, Y, Wang, Y, Kolokythas, A, Dai, Y, Zhou, X
The Biochemical journal. 2011;(1):23-31
-
-
Free full text
-
Abstract
Down-regulation of miR-138 (microRNA-138) has been frequently observed in various cancers, including HNSCC (head and neck squamous cell carcinoma). Our previous studies suggest that down-regulation of miR-138 is associated with mesenchymal-like cell morphology and enhanced cell migration and invasion. In the present study, we demonstrated that these miR-138-induced changes were accompanied by marked reduction in E-cad (E-cadherin) expression and enhanced Vim (vimentin) expression, characteristics of EMT (epithelial-mesenchymal transition). On the basis of a combined experimental and bioinformatics analysis, we identified a number of miR-138 target genes that are associated with EMT, including VIM, ZEB2 (zinc finger E-box-binding homeobox 2) and EZH2 (enhancer of zeste homologue 2). Direct targeting of miR-138 to specific sequences located in the mRNAs of the VIM, ZEB2 and EZH2 genes was confirmed using luciferase reporter gene assays. Our functional analyses (knock-in and knock-down) demonstrated that miR-138 regulates the EMT via three distinct pathways: (i) direct targeting of VIM mRNA and controlling the expression of VIM at a post-transcriptional level, (ii) targeting the transcriptional repressors (ZEB2) which in turn regulating the transcription activity of the E-cad gene, and (iii) targeting the epigenetic regulator EZH2 which in turn modulates its gene silencing effects on the downstream genes including E-cad. These results, together with our previously observed miR-138 effects on cell migration and invasion through targeting RhoC (Rho-related GTP-binding protein C) and ROCK2 (Rho-associated, coiled-coil-containing protein kinase 2) concurrently, suggest that miR-138 is a multi-functional molecular regulator and plays major roles in EMT and in HNSCC progression.